Evidence map›Paper›PMID 33748946›Full record

ReviewBiotechnology and bioengineering2021

The role of extracellular DNA in the formation, architecture, stability, and treatment of bacterial biofilms.

Hannah Panlilio, Charles V Rice

Open access · greenAbstract readReview
In one paragraph

Review in Biotechnology and bioengineering, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 83 papers.

0numbers the graph read from it
0cells of the map it votes in
83citing papers in PubMed
8.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

83 citing papers in PubMed, 170 citations in OpenAlex.

  1. Review
  2. Diversity of biofilm architectures within the genusApplied and environmental microbiology · 2026
    Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. UnderstandingMicroorganisms · 2026
    Review
  12. Review
  13. Review
  14. Article
  15. Recent advances in membrane vesicles ofJournal of oral microbiology · 2026
    Review
  16. Unveiling the dual role ofPlant signaling & behavior · 2025
    Article
  17. Review
  18. Article
  19. Domain antibody-displayed phages as a novel biofilm-targeted therapy for Staphylococcus aureus.International microbiology : the official journal of the Spanish Society for Microbiology · 2025
    Article
  20. Article

23 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Hannah PanlilioDepartment of Chemistry and Biochemistry, Stephenson Life Sciences Research Center, University of Oklahoma, Norman, Oklahoma, USA.
Charles V RiceDepartment of Chemistry and Biochemistry, Stephenson Life Sciences Research Center, University of Oklahoma, Norman, Oklahoma, USA.ORCID 0000-0003-1424-405X
University of Oklahoma · US

Funding

Antibiotic Potentiators Targeting Biofilms of MRSA and MRSER03AI142420 · NIAID · UNIVERSITY OF OKLAHOMA · PI RICE, CHARLES V · 2019 to 2020
$142k
National Institute of Allergy and Infectious Diseases R03AI142420-01NIAID NIH HHS R03 AI142420
6 · The paper itself

Abstract

Advances in biotechnology to treat and cure human disease have markedly improved human health and the development of modern societies. However, substantial challenges remain to overcome innate biological factors that thwart the activity and efficacy of pharmaceutical therapeutics. Until recently, the importance of extracellular DNA (eDNA) in biofilms was overlooked. New data reveal its extensive role in biofilm formation, adhesion, and structural integrity. Different approaches to target eDNA as anti-biofilm therapies have been proposed, but eDNA and the corresponding biofilm barriers are still difficult to disrupt. Therefore, more creative approaches to eradicate biofilms are needed. The production of eDNA often originates with the genetic material of bacterial cells through cell lysis. However, genomic DNA and eDNA are not necessarily structurally or compositionally identical. Variations are noteworthy because they dictate important interactions within the biofilm. Interactions between eDNA and biofilm components may as well be exploited as alternative anti-biofilm strategies. In this review, we discuss recent developments in eDNA research, emphasizing potential ways to disrupt biofilms. This review also highlights proteins, exopolysaccharides, and other molecules interacting with eDNA that can serve as anti-biofilm therapeutic targets. Overall, the array of diverse interactions with eDNA is important in biofilm structure, architecture, and stability.

Indexed as

BiofilmsBacteriaBacterial ProteinsChromosomes, BacterialDNA, BacterialMicroscopy, Electron, ScanningProtein BindingBacterial ProteinsDNA, Bacterialanti-biofilm therapiesbiofilmseDNAeDNA-interactionseDNA therapy

Identifiers

PMID33748946
PMCPMC8667714
OpenAlexW3137200117

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.